Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

FDA confirms more recalls for Johnson & Johnson heart pumps due to malfunction risk
The issue, first announced to the public in February, has been linked to 22 serious injuries. Customers are urged to review the updated instructions for use to avoid any potential complications.
Johnson & Johnson launches 3 new stroke devices
These devices were developed to help clinicians reach and remove distal clots associated with significant pain and swelling. If left untreated, such clots can lead to medical emergencies and even death.
FDA approves next-generation CardioMEMS reader for heart failure monitoring
The updated reader is 60% smaller and offers built-in WiFi connectivity. It works with an implantable sensor to monitor a patient's PA pressure.
GLP-1 drugs and healthy habits work together to boost heart health, Harvard study confirms
When patients on GLP-1 therapy also make healthy lifestyle choices—getting enough sleep and exercising, for example—the benefits are significantly greater.
AI helps identify risk in adults with congenital heart disease
STS plans on using new research out of Mayo Clinic to help with the development of a surgical risk calculator for adults with this challenging condition.

FDA recall medical device recall product recall

FDA confirms more recalls for Johnson & Johnson heart pumps due to malfunction risk

The issue, first announced to the public in February, has been linked to 22 serious injuries. Customers are urged to review the updated instructions for use to avoid any potential complications.

Cereglide 57 image courtesy of Johnson & Johnson MedTech.

Johnson & Johnson launches 3 new stroke devices

These devices were developed to help clinicians reach and remove distal clots associated with significant pain and swelling. If left untreated, such clots can lead to medical emergencies and even death.

Abbott has secured U.S. Food and Drug Administration (FDA) approval for its CardioMEMS HERO device, a next-generation pulmonary artery (PA) pressure reader for heart failure patients.

FDA approves next-generation CardioMEMS reader for heart failure monitoring

The updated reader is 60% smaller and offers built-in WiFi connectivity. It works with an implantable sensor to monitor a patient's PA pressure.

GLP-1 drugs and healthy habits work together to boost heart health, Harvard study confirms

When patients on GLP-1 therapy also make healthy lifestyle choices—getting enough sleep and exercising, for example—the benefits are significantly greater.

AI helps identify risk in adults with congenital heart disease

STS plans on using new research out of Mayo Clinic to help with the development of a surgical risk calculator for adults with this challenging condition.

Image of the A-FLUX Reducer System for chest pain by VahatiCor

New heart device for ‘no-option’ chest pain patients shows early potential

The self-expanding, recapturable coronary sinus reducer was associated with a safe implant procedure and "promising" outcomes after six months. Additional research is already underway.

Novartis building massive new radioligand manufacturing facility as part of $23B investment in US

The 46,000 square foot Denton site will be the fifth Novartis has constructed stateside. The company expects it to be fully operational by 2028.

Vascular imaging at heart of $71M fraud scheme—DOJ announces prison sentences

The years-long scheme involved sending kickbacks to physicians who ordered unnecessary transcranial doppler exams. Two conspirators have now been sentenced to prison and ordered to pay substantial fines.